Início › Carcinoma de Células Escamosas de Cabeça e Pescoço › Califórnia
Ensaios clínicos de Carcinoma de Células Escamosas de Cabeça e Pescoço em Califórnia
72 estudos para Carcinoma de Células Escamosas de Cabeça e Pescoço estão buscando participantes em locais em Califórnia.
Cidades em Califórnia
- Los Angeles42 estudos
- Baldwin Park16 estudos
- San Diego14 estudos
- Santa Monica13 estudos
- Irvine11 estudos
- San Francisco10 estudos
- Orange8 estudos
- Sacramento8 estudos
- Mountain View8 estudos
- Newport Beach5 estudos
- Fullerton3 estudos
- Santa Rosa3 estudos
Texto oficial do estudo (Inglês)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06992427A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- City of Hope National Medical Center, Duarte
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06465069FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site #0107, La Jolla
- Site #0106, Los Angeles
- Site#0144, Sacramento
- e mais 2
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06788990Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #59, Santa Barbara
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05176483Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- VA Palo Alto Health Care System, Palo Alto
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06589804A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- City of Hope National Medical Center, Duarte
- City of Hope at Irvine Lennar, Irvine
- Ronald Reagan UCLA Medical Center, Los Angeles
- e mais 3
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07090499A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 9, La Jolla
- ALX Center 11, Santa Monica
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07085091A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07744126A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Duarte
- Research Site, Los Angeles
- Research Site, Newport Beach
- e mais 1
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05877599A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Providence St Jude Medical Center, Fullerton
- Scripps Health, La Jolla
- Valkyrie Clinical Trials, Los Angeles
- e mais 4
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07276399Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06980038BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Tower Cancer Research Foundation, Beverly Hills
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
- e mais 4
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05136196JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
- City of Hope, Duarte
- University of California at San Diego Moores Cancer Center, La Jolla
- UCLA Hematology Oncology, Los Angeles
- e mais 1
RecrutandoFase 3
Idades 60 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT04892173A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
- City of Hope, Duarte
RecrutandoFase 1
Idades de 18 a 74 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07219212Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Precision NextGen Oncology, Beverly Hills
- OPN Healthcare, Inc, Glendale
- University of Southern California, Los Angeles
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06047379A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, Santa Monica
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07229313Intratumoral N17350 in Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
- Scripps Clinic Torrey Pines - La Jolla, San Diego
- e mais 1
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07339176Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Kaiser Permanente-Anaheim, Anaheim
- Kaiser Permanente-Bellflower, Bellflower
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- e mais 3
RecrutandoFase 2
Idades de 18 a 79 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT04671667Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Beverly Hills Cancer Center, Beverly Hills
- City of Hope Cancer Center, Duarte
- University of California Irvine Medical Center, Orange
- e mais 1
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT05983432Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
- Stanford University, Stanford
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT06736379A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- City of Hope, Duarte
- City of Hope, Irvine, Irvine
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07109726ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of California, San Diego, La Jolla
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Redwood City, Redwood City
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
- Mercy Cancer Center - Carmichael, Carmichael
- e mais 11
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT02734537A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Site 105 - START Los Angeles, Los Angeles
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT07462377A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- City of Hope, Duarte
- USC/Norris Comprehensive Cancer Center, Los Angeles
- University of California, Los Angeles, Los Angeles
- e mais 2
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06163534Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
- City of Hope Comprehensive Cancer Center, Duarte
- City of Hope at Irvine Lennar, Irvine
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07156227A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- START Los Angeles, Los Angeles
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07602842FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- UC San Diego Moores Cancer Center, La Jolla
- University of Southern California, Los Angeles
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07216105A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- University of California Los Angeles, Los Angeles
- Samuel Oschin Cancer Center, Los Angeles
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06769698A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
- City Of Hope Comprehensive Cancer Center /ID# 276550, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278432, Irvine
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT07241039Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- UC San Diego Moores Cancer Center, La Jolla
- Stanford Cancer Institute Palo Alto, Palo Alto
- UC San Diego Medical Center - Hillcrest, San Diego
- e mais 2
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT04333537A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Community Cancer Institute, Clovis
- USC/Norris Comprehensive Cancer Center, Los Angeles
- Hoag Memorial Hospital Presbyterian, Newport Beach
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT04895709Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- UC San Diego Health System - Encinitas, Encinitas
- UC San Diego Moores Cancer Center, La Jolla
- UC San Diego Medical Center - Hillcrest, San Diego
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
- Tower Cancer Research Foundation, Beverly Hills
- USC / Norris Comprehensive Cancer Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT07441681Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- USC Norris Comprehensive Cancer Center, Los Angeles
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 13 de ago. de 2026 · NCT05985655SMP-3124LP in Adults With Advanced Solid Tumors
- Cedars Sinai Medical Center, Los Angeles
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT06526819A Study of MGC026 in Participants With Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Los Angeles Cancer Network, Los Angeles
- Pih Health Hematology Medical Oncology, Whittier
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06330064Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- City of Hope, Duarte
- Los Angeles Cancer Network, Glendale
- California Research Institute, Los Angeles
- e mais 3
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT04198766A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- UCSD, La Jolla
- Sharp Healthcare, San Diego
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT03526835Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.